Strategies for five tumour markers in the screening and diagnosis of female breast cancer

ObjectiveThis study evaluated the diagnostic value of different combinations of five commonly used tumour markers and screened the best combination of tumour markers.MethodsRegression analysis was used to evaluate 185 patients with suspected breast cancer admitted to Mianyang Central Hospital from J...

Full description

Bibliographic Details
Main Authors: Jun Luo, Jianbo Xiao, Yuwei Yang, Gang Chen, Dong Hu, Jiawei Zeng
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.1055855/full
_version_ 1797945471751159808
author Jun Luo
Jianbo Xiao
Yuwei Yang
Gang Chen
Dong Hu
Jiawei Zeng
author_facet Jun Luo
Jianbo Xiao
Yuwei Yang
Gang Chen
Dong Hu
Jiawei Zeng
author_sort Jun Luo
collection DOAJ
description ObjectiveThis study evaluated the diagnostic value of different combinations of five commonly used tumour markers and screened the best combination of tumour markers.MethodsRegression analysis was used to evaluate 185 patients with suspected breast cancer admitted to Mianyang Central Hospital from January 2020 to December 2021. The differences of five tumour markers between a breast cancer group and a benign lesion group were analysed. The sensitivity and specificity of five tumour markers were compared.ResultsOf 185 patients with suspected breast cancer, 108 patients had breast cancer and 77 patients had benign breast tumours. The detection results of carcinoembryonic antigen (CEA), alpha fetoprotein (AFP), carbohydrate antigen 125 (CA125), carbohydrate antigen 199 (CA199) and carbohydrate antigen 153 (CA153) in patients with breast cancer were significantly higher than those in patients with benign breast tumours. In the analysis of the single-detection results of tumour markers, CEA had the highest sensitivity (23.94%), CA153 had the highest specificity (96.43%), AFP had the highest accuracy (47.66%) and CA153 had the highest area under the curve (AUC) value (0.727). With the increase of parallel indicators, the sensitivity, accuracy and AUC value increased in turn, and the increase was obvious in the front. The increase began to slow down after the three parallel indicators. Among the different combinations of three parallel detections of breast cancer tumour markers, the highest sensitivity was AFP + CEA + CA153 (83.46%), the highest accuracy was AFP + CEA + CA153 and AFP + CA153 + CA125 (80.25%), and the highest AUC was CEA + CA125 + CA199 (0.922).ConclusionAFP, CA153 and CA199 are recommended for clinical diagnosis of breast cancer. In routine physical examination and early breast cancer screening, the optimal combination of AFP + CEA + CA153 three parallel tests is recommended.
first_indexed 2024-04-10T20:55:38Z
format Article
id doaj.art-6f89c00ae1f14c98b10cb7b7eb8d7a2a
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-04-10T20:55:38Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-6f89c00ae1f14c98b10cb7b7eb8d7a2a2023-01-23T06:05:51ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-01-011210.3389/fonc.2022.10558551055855Strategies for five tumour markers in the screening and diagnosis of female breast cancerJun LuoJianbo XiaoYuwei YangGang ChenDong HuJiawei ZengObjectiveThis study evaluated the diagnostic value of different combinations of five commonly used tumour markers and screened the best combination of tumour markers.MethodsRegression analysis was used to evaluate 185 patients with suspected breast cancer admitted to Mianyang Central Hospital from January 2020 to December 2021. The differences of five tumour markers between a breast cancer group and a benign lesion group were analysed. The sensitivity and specificity of five tumour markers were compared.ResultsOf 185 patients with suspected breast cancer, 108 patients had breast cancer and 77 patients had benign breast tumours. The detection results of carcinoembryonic antigen (CEA), alpha fetoprotein (AFP), carbohydrate antigen 125 (CA125), carbohydrate antigen 199 (CA199) and carbohydrate antigen 153 (CA153) in patients with breast cancer were significantly higher than those in patients with benign breast tumours. In the analysis of the single-detection results of tumour markers, CEA had the highest sensitivity (23.94%), CA153 had the highest specificity (96.43%), AFP had the highest accuracy (47.66%) and CA153 had the highest area under the curve (AUC) value (0.727). With the increase of parallel indicators, the sensitivity, accuracy and AUC value increased in turn, and the increase was obvious in the front. The increase began to slow down after the three parallel indicators. Among the different combinations of three parallel detections of breast cancer tumour markers, the highest sensitivity was AFP + CEA + CA153 (83.46%), the highest accuracy was AFP + CEA + CA153 and AFP + CA153 + CA125 (80.25%), and the highest AUC was CEA + CA125 + CA199 (0.922).ConclusionAFP, CA153 and CA199 are recommended for clinical diagnosis of breast cancer. In routine physical examination and early breast cancer screening, the optimal combination of AFP + CEA + CA153 three parallel tests is recommended.https://www.frontiersin.org/articles/10.3389/fonc.2022.1055855/fullbreast cancerAFPCEACA125CA153CA199
spellingShingle Jun Luo
Jianbo Xiao
Yuwei Yang
Gang Chen
Dong Hu
Jiawei Zeng
Strategies for five tumour markers in the screening and diagnosis of female breast cancer
Frontiers in Oncology
breast cancer
AFP
CEA
CA125
CA153
CA199
title Strategies for five tumour markers in the screening and diagnosis of female breast cancer
title_full Strategies for five tumour markers in the screening and diagnosis of female breast cancer
title_fullStr Strategies for five tumour markers in the screening and diagnosis of female breast cancer
title_full_unstemmed Strategies for five tumour markers in the screening and diagnosis of female breast cancer
title_short Strategies for five tumour markers in the screening and diagnosis of female breast cancer
title_sort strategies for five tumour markers in the screening and diagnosis of female breast cancer
topic breast cancer
AFP
CEA
CA125
CA153
CA199
url https://www.frontiersin.org/articles/10.3389/fonc.2022.1055855/full
work_keys_str_mv AT junluo strategiesforfivetumourmarkersinthescreeninganddiagnosisoffemalebreastcancer
AT jianboxiao strategiesforfivetumourmarkersinthescreeninganddiagnosisoffemalebreastcancer
AT yuweiyang strategiesforfivetumourmarkersinthescreeninganddiagnosisoffemalebreastcancer
AT gangchen strategiesforfivetumourmarkersinthescreeninganddiagnosisoffemalebreastcancer
AT donghu strategiesforfivetumourmarkersinthescreeninganddiagnosisoffemalebreastcancer
AT jiaweizeng strategiesforfivetumourmarkersinthescreeninganddiagnosisoffemalebreastcancer